ASH 2023 Insights: "HARBOR Trial - Elenestinib, an Investigational, Next Gen KIT D816V Inhibitor, in Patients With Indolent Systemic Mastocytosis"

27 views
December 19, 2023
0 Comments
Login to view comments. Click here to Login